A detailed history of Amalgamated Bank transactions in Sight Sciences, Inc. stock. As of the latest transaction made, Amalgamated Bank holds 755 shares of SGHT stock, worth $4,673. This represents 0.0% of its overall portfolio holdings.

Number of Shares
755
Previous 3,086 75.53%
Holding current value
$4,673
Previous $16,000 75.0%
% of portfolio
0.0%
Previous 0.0%

Shares

7 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

Apr 23, 2024

SELL
$4.02 - $5.89 $9,370 - $13,729
-2,331 Reduced 75.53%
755 $4,000
Q4 2023

Feb 06, 2024

SELL
$1.29 - $5.86 $290 - $1,318
-225 Reduced 6.8%
3,086 $16,000
Q2 2023

Aug 11, 2023

BUY
$7.46 - $10.67 $6,975 - $9,976
935 Added 39.35%
3,311 $27,000
Q1 2023

May 02, 2023

SELL
$8.44 - $13.35 $3,629 - $5,740
-430 Reduced 15.32%
2,376 $21,000
Q3 2022

Nov 09, 2022

BUY
$6.1 - $11.41 $30 - $57
5 Added 0.18%
2,806 $18,000
Q2 2022

Aug 15, 2022

BUY
$6.61 - $11.99 $746 - $1,354
113 Added 4.2%
2,801 $25,000
Q1 2022

Jun 30, 2022

BUY
$11.56 - $17.9 $31,073 - $48,115
2,688 New
2,688 $31,000

Others Institutions Holding SGHT

About Sight Sciences, Inc.


  • Ticker SGHT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 47,826,200
  • Market Cap $296M
  • Description
  • Sight Sciences, Inc., an ophthalmic medical device company, engages in the development and commercialization of surgical and nonsurgical technologies for the treatment of eye diseases. The company's products include OMNI Surgical System, a therapeutic device used by ophthalmic surgeons to reduce intraocular pressure in adult glaucoma patients; a...
More about SGHT
Track This Portfolio

Track Amalgamated Bank Portfolio

Follow Amalgamated Bank and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Amalgamated Bank, based on Form 13F filings with the SEC.

News

Stay updated on Amalgamated Bank with notifications on news.